Present and future of cancer immunotherapy: A tumor microenvironmental perspective

about

Present and future of cancer immunotherapy: A tumor microenvironmental perspective

Item

http://www.wikidata.org/entity/Q57144510

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Present and future of cancer immunotherapy: A tumor microenvironmental perspective

@en

Present and future of cancer immunotherapy: A tumor microenvironmental perspective

@nl

type

Item

label

Present and future of cancer immunotherapy: A tumor microenvironmental perspective

@en

Present and future of cancer immunotherapy: A tumor microenvironmental perspective

@nl

prefLabel

Present and future of cancer immunotherapy: A tumor microenvironmental perspective

@en

Present and future of cancer immunotherapy: A tumor microenvironmental perspective

@nl

P1476

Present and future of cancer immunotherapy: A tumor microenvironmental perspective

@en

P2093

Jiuwei Cui

http://www.w3.org/2001/XMLSchema#string

Yu Yu

http://www.w3.org/2001/XMLSchema#string

P2860

Understanding the Warburg effect: the metabolic requirements of cell proliferation

A Mini-Review for Cancer Immunotherapy: Molecular Understanding of PD-1/PD-L1 Pathway & Translational Blockade of Immune Checkpoints

Immune Effects of Chemotherapy, Radiation, and Targeted Therapy and Opportunities for Combination With Immunotherapy

Molecular mechanisms of T cell co-stimulation and co-inhibition

The effect of radiation on the immune response to cancers

Immune escape mechanisms as a guide for cancer immunotherapy

The pancreas cancer microenvironment

Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints.

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Stromal antigen targeting by a humanised monoclonal antibody: an early phase II trial of sibrotuzumab in patients with metastatic colorectal cancer

P304

4105-4113

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2018.9219

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30214551

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

cancer research

P932

6126324

http://www.w3.org/2001/XMLSchema#string